400 related articles for article (PubMed ID: 29176760)
1. Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.
Bruxelle JF; Mizrahi A; Hoÿs S; Collignon A; Janoir C; Péchiné S
PLoS One; 2017; 12(11):e0187212. PubMed ID: 29176760
[TBL] [Abstract][Full Text] [Related]
2. Protection against Clostridium difficile infection in a hamster model by oral vaccination using flagellin FliC-loaded pectin beads.
Bruxelle JF; Tsapis N; Hoys S; Collignon A; Janoir C; Fattal E; Péchiné S
Vaccine; 2018 Sep; 36(40):6017-6021. PubMed ID: 30172633
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic properties of the surface layer precursor of Clostridium difficile and vaccination assays in animal models.
Bruxelle JF; Mizrahi A; Hoys S; Collignon A; Janoir C; Péchiné S
Anaerobe; 2016 Feb; 37():78-84. PubMed ID: 26505926
[TBL] [Abstract][Full Text] [Related]
4. Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile.
Péchiné S; Janoir C; Boureau H; Gleizes A; Tsapis N; Hoys S; Fattal E; Collignon A
Vaccine; 2007 May; 25(20):3946-54. PubMed ID: 17433506
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile disease.
Ghose C; Verhagen JM; Chen X; Yu J; Huang Y; Chenesseau O; Kelly CP; Ho DD
Infect Immun; 2013 Jun; 81(6):2190-6. PubMed ID: 23545305
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC.
Ghose C; Eugenis I; Sun X; Edwards AN; McBride SM; Pride DT; Kelly CP; Ho DD
Emerg Microbes Infect; 2016 Feb; 5(2):e8. PubMed ID: 26839147
[TBL] [Abstract][Full Text] [Related]
7. Variability of Clostridium difficile surface proteins and specific serum antibody response in patients with Clostridium difficile-associated disease.
Péchiné S; Janoir C; Collignon A
J Clin Microbiol; 2005 Oct; 43(10):5018-25. PubMed ID: 16207956
[TBL] [Abstract][Full Text] [Related]
8. Construction and evaluation of the immune protection of a recombinant divalent protein composed of the MrpA from MR/P fimbriae and flagellin of Proteus mirabilis strain against urinary tract infection.
Habibi M; Asadi Karam MR; Bouzari S
Microb Pathog; 2018 Apr; 117():348-355. PubMed ID: 29452195
[TBL] [Abstract][Full Text] [Related]
9. Active immunization of hamsters against Clostridium difficile infection using surface-layer protein.
Ní Eidhin DB; O'Brien JB; McCabe MS; Athié-Morales V; Kelleher DP
FEMS Immunol Med Microbiol; 2008 Mar; 52(2):207-18. PubMed ID: 18093141
[TBL] [Abstract][Full Text] [Related]
10. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
[TBL] [Abstract][Full Text] [Related]
11. A heterologous prime-boost route of vaccination based on the truncated MrpH adhesin and adjuvant properties of the flagellin from Proteus mirabilis against urinary tract infections.
Asadi Karam MR; Shirzad AM; Habibi M; Bouzari S
Int Immunopharmacol; 2018 May; 58():40-47. PubMed ID: 29549718
[TBL] [Abstract][Full Text] [Related]
12. Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.
Giannasca PJ; Zhang ZX; Lei WD; Boden JA; Giel MA; Monath TP; Thomas WD
Infect Immun; 1999 Feb; 67(2):527-38. PubMed ID: 9916055
[TBL] [Abstract][Full Text] [Related]
13. Antigen-Specific Mucosal Immunity Regulates Development of Intestinal Bacteria-Mediated Diseases.
Fujimoto K; Kawaguchi Y; Shimohigoshi M; Gotoh Y; Nakano Y; Usui Y; Hayashi T; Kimura Y; Uematsu M; Yamamoto T; Akeda Y; Rhee JH; Yuki Y; Ishii KJ; Crowe SE; Ernst PB; Kiyono H; Uematsu S
Gastroenterology; 2019 Dec; 157(6):1530-1543.e4. PubMed ID: 31445037
[TBL] [Abstract][Full Text] [Related]
14. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
Huang Y; Hajishengallis G; Michalek SM
Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
[TBL] [Abstract][Full Text] [Related]
15. Development of vaccine for Clostridium difficile infection using membrane fraction of nontoxigenic Clostridium difficile.
Senoh M; Iwaki M; Yamamoto A; Kato H; Fukuda T; Shibayama K
Microb Pathog; 2018 Oct; 123():42-46. PubMed ID: 29959036
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile TxAC314 and SLP-36kDa enhance the immune response toward a co-administered antigen.
Brun P; Scarpa M; Grillo A; Palù G; Mengoli C; Zecconi A; Spigaglia P; Mastrantonio P; Castagliuolo I
J Med Microbiol; 2008 Jun; 57(Pt 6):725-731. PubMed ID: 18480329
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A.
Ward SJ; Douce G; Figueiredo D; Dougan G; Wren BW
Infect Immun; 1999 May; 67(5):2145-52. PubMed ID: 10225867
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L; Filler M; Sjöholm I
Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
[TBL] [Abstract][Full Text] [Related]
19. Novel Chimeric Protein Vaccines Against
Wang S; Wang Y; Cai Y; Kelly CP; Sun X
Front Immunol; 2018; 9():2440. PubMed ID: 30405630
[No Abstract] [Full Text] [Related]
20. Use of recombinant flagellin in oil-in-water emulsions enhances hemagglutinin-specific mucosal IgA production and IL-17 secreting T cells against H5N1 avian influenza virus infection.
Lai CH; Tang N; Jan JT; Huang MH; Lu CY; Chiang BL; Huang LM; Wu SC
Vaccine; 2015 Aug; 33(35):4321-9. PubMed ID: 25858857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]